Authors


Lena Anthony

Latest:

Grappling with the long-term care market

The geriatric-dominated LTC market is growing, but has unique constraints



Nicholas Saraceno, Editor

Latest:

Peer Exchange: Pharma Leaders Stress Tailored, Balanced Approach to Long-Term Manufacturing Strategy (Episode 8)

In the eighth part of this roundtable discussion, supply chain experts emphasize that effective manufacturing strategies depend on product type, market location, and regulatory complexity, requiring a careful balance between outsourcing, internal production, regional distribution, and patient-centric priorities.


John Cervione, Blue Fin Group

Latest:

Marching up the channel management curve

Financial and business changes are driving an evolution in channel management strategies


Drug Administration

Latest:

Laying the foundation for a national system for evidence generation

Sharing clinical data—EvGen—will improve both drug development and health outcomes analysis



Nicholas Basta

Latest:

HDA calls for withdrawal of FDA’s latest DSCSA guidance on the ‘enhanced drug distribution system’

FDA’s recommended guidance is for a system that ‘does not exist, cannot be built by 2023, and poses unacceptable security and compliance risks,’ says alliance


By Bruce Kratz

Latest:

How cloud-based IT systems address FDA validation requirements

Paper validation records will disappear in the face of continuous validation


Mark Lipowicz

Latest:

2014 Biopharma cold-chain forecast

Global industry will spend $8.36 billion on cold chain logistics this year


By Paul Sullivan, Noble

Latest:

Integrating patient training into product launches

The growing market for self-administered injectables calls for better patient-training resources





Sterling Barnett, Deloitte Consulting LLP

Latest:

Developing a Center of Excellence (COE) for Financial Planning & Analysis

Life sciences CFOs can address growing cost pressures through decision support centralization


Neeraj Singhal, Cegedim Dendrite

Latest:

Key Account Management: A Win-Win Proposition for Pharmaceutical Companies and Their Major Customers

Reorganizing a sales force into key account teams requires more planning and coordination. Access to real-time account information enhances the team effort.


Charles Bennett, Pfizer

Latest:

Networking for life science logistics

The Health & Personal Care Logistics Conference brings industry leaders together


Jo Fearnhead-Wymbs, Ashfield Healthcare Communications

Latest:

Supporting pharma’s shift in focus from patient 'outputs’ to ‘outcomes’

The rise of the patient voice and increased acceptance of remote engagement are sparking a culture change across the supply chain


Matt Jackson, Matt Highfield

Latest:

A scientific approach to site selection

Applying a consistent framework to choose locations can help optimize R&D and drive cost reduction for pharmaceutical companies of all sizes



By Valerie Sullivan

Latest:

Patient access strategy: specialty pharmacy, hub—or both?

Do you need to hire a hub service for your Patient Access Strategy or can you get by with a good specialty pharmacy


Harry S. Bloch

Latest:

Provisional patent technology filed for cardiovascular disease is for sale or joint venture

Combining sublingual nitroglycerin and aspirin in a tablet or other embodiments could be a significant global market opportunity


Wynn Bailey, PwC US

Latest:

Pharma 2020: Supplying the Future

Redesigning supply chains could change the shape of bio/pharma



Melissa Leonhauser, SDI

Latest:

OTC and Retail Purchases Round out the View of Patient Behavior

Combining prescription and OTC purchasing patterns gives deeper insights into patient behavior


Lee Dickinson, Pharma Tech Industries

Latest:

Technology Transfer

How Contract Manufacturers Can Help Pharma Through The Era of Divestiture


Omer Demiray

Latest:

Pharma is under-managing its multi-channel marketing efforts

Survey shows that most digital channels are still experiments with little oversight or follow-through



Bryan Cox, Pharma Tech Industries

Latest:

Pharma's bread and butter is still made with powder

Despite a flurry of specialty pharmaceuticals in innovative formats, traditional powder-based dosages will always be a mainstay


Margot Drees, GHX

Latest:

Preparing for a serialized supply chain

Upcoming California regulatory mandates, and the prospect of a national compliance requirement, are focusing industry attention. Here's what some industry leaders have to say


Edward Hensley, AssistRx

Latest:

Elevating brand outreach in the age of Covid

Using technology to enable processes, drive cost savings, and deliver better patient outcomes

© 2025 MJH Life Sciences

All rights reserved.